Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12613000663752Phase 4Not yet recruiting
Phase 4 trial of gabapentin in postoperative pain (2 arms), sponsored by University of Otago. Primary endpoint: Post-operative pain. Planned start Jan 2014; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12613000663752.